RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Career Considerations: Generic vs. Innovator Pharmaceutical Regulatory Affairs

Career Considerations: Generic vs. Innovator Pharmaceutical Regulatory Affairs

Posted 01 April 2009

A regulatory career can be highly rewarding for a variety of reasons, including one's involvement in the delivery of exciting healthcare products to patients in need and exposure to numerous aspects of the product development cycle. The wide array of career paths within and across the profession makes this key function that much more gratifying, especially for someone considering a change in focus within regulatory affairs. There are some factors worth considering when determining the next steps in a regulatory career. To illustrate some of these considerations, this article focuses on basic similarities and differences between regulatory roles in generic and innovator pharmaceutical firms.

 

© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe